how much weight loss on glp 1 Poll: in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Understanding GLP-1 and Its Role

manufacturing base provides insulation from potential trade or tariff risk

DOI: 10.1210/endrev/bnad019 Imai S & Guarente L (2014) Trends in Cell Biology , 24(8): 464471 (npj Aging) Foundational review confirming the intimate connection between NAD+ availability and sirtuin activity as a conserved ageing/longevity regulatory axis

Patients taking GLP-1 receptor agonists had a 1.15 HR of developing NAION compared to control

The protective and antiinflammatory effects of a modified glucagon-like peptide-2 dimer in inflammatory bowel disease

(Prior trials of injectable GLP-1-based therapies showed ~ 16% loss with semaglutide and ~21% with tirzepatide)